Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada
Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, View ORCID ProfileAndrew P Costa, View ORCID ProfileJeffrey C Kwong
doi: https://doi.org/10.1101/2022.09.29.22280526
Ramandip Grewal
1Public Health Ontario, Toronto, Ontario, Canada
Lena Nguyen
2ICES, Toronto, Ontario, Canada
Sarah A Buchan
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
Sarah E Wilson
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
Andrew P Costa
6Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
7Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
8Centre for Integrated Care, St. Joseph’s Health System, Hamilton, Ontario, Canada
Jeffrey C Kwong
1Public Health Ontario, Toronto, Ontario, Canada
2ICES, Toronto, Ontario, Canada
3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
4Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
9Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
10University Health Network, Toronto, Ontario, Canada
Posted September 30, 2022.
Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada
Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, Andrew P Costa, Jeffrey C Kwong
medRxiv 2022.09.29.22280526; doi: https://doi.org/10.1101/2022.09.29.22280526
Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada
Ramandip Grewal, Lena Nguyen, Sarah A Buchan, Sarah E Wilson, Andrew P Costa, Jeffrey C Kwong
medRxiv 2022.09.29.22280526; doi: https://doi.org/10.1101/2022.09.29.22280526
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12740)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4346)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)